Connect
MJA
MJA

Reducing drug-related harm: Australia leads the way

Alison J Ritter, Alex D Wodak and J Nick Crofts
Med J Aust 2004; 181 (5): . || doi: 10.5694/j.1326-5377.2004.tb06260.x
Published online: 6 September 2004

Harm-reduction approaches are more easily embedded in policy when drugs are legally regulated


  • 1 Turning Point Alcohol and Drug Centre, Melbourne, VIC.
  • 2 Alcohol and Drug Service, St Vincent’s Hospital, Sydney, NSW.
  • 3 Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, VIC.


Correspondence: 

  • 1. Health Outcomes International; The National Centre for HIV Epidemiology and Clinical Research; Centre of Health Economics, York University (Drummond M). Return on investment in needle and syringe programs in Australia. Australian Government Department of Health and Ageing, October 2002. Available at: www.health.gov.au/pubhlth/publicat/document/metadata/roireport.htm (accessed Aug 2004).

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.